Frank J. Hsu - Net Worth and Insider Trading

Frank J. Hsu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Frank J. Hsu owns 3 companies in total, including Oncternal Therapeutics Inc (ONCT) , Apexigen Inc (APGN) , and Brookline Capital Acquisition Corp (BCACU) .

Click here to see the complete history of Frank J. Hsu’s form 4 insider trades.

Insider Ownership Summary of Frank J. Hsu

Ticker	Comapny	Transaction Date	Type of Owner
ONCT	Oncternal Therapeutics Inc	2019-08-26	Chief Medical Officer
APGN	Apexigen Inc	2022-07-29	Chief Medical Officer
BCACU	Brookline Capital Acquisition Corp	2022-07-29	Chief Medical Officer

Frank J. Hsu Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Frank J. Hsu Ownership Network

Ownership Network List of Frank J. Hsu

No Data

Ownership Network Relation of Frank J. Hsu

Frank J. Hsu Owned Company Details

What does Oncternal Therapeutics Inc do?

Who are the key executives at Oncternal Therapeutics Inc?

Frank J. Hsu is the Chief Medical Officer of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .

Oncternal Therapeutics Inc (ONCT) Insider Trades Summary

Over the past 18 months, Frank J. Hsu made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 28,000 shares made by Gunnar F. Kaufmann , and a net purchase of 980 shares made by David F Hale .

In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 12,380 shares were bought by its insiders, resulting in a net purchase of 11,400 shares.

Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oncternal Therapeutics Inc Insider Transactions

No Available Data

What does Apexigen Inc do?

Who are the key executives at Apexigen Inc?

Frank J. Hsu is the Chief Medical Officer of Apexigen Inc. Other key executives at Apexigen Inc include Chief Operating Officer Francis Willard Sarena , Chief Financial Officer William E. Duke , and SVP & Finance and Operations Amy Wong .

Apexigen Inc (APGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Apexigen Inc (APGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Apexigen Inc (APGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Apexigen Inc (APGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Apexigen Inc Insider Transactions

No Available Data

What does Brookline Capital Acquisition Corp do?

Who are the key executives at Brookline Capital Acquisition Corp?

Frank J. Hsu is the Chief Medical Officer of Brookline Capital Acquisition Corp. Other key executives at Brookline Capital Acquisition Corp include Chief Operating Officer Francis Willard Sarena , Chief Financial Officer William E. Duke , and SVP & Finance and Operations Amy Wong .

Brookline Capital Acquisition Corp (BCACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Brookline Capital Acquisition Corp (BCACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Brookline Capital Acquisition Corp (BCACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Brookline Capital Acquisition Corp (BCACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Brookline Capital Acquisition Corp Insider Transactions

No Available Data

Frank J. Hsu Mailing Address

Above is the net worth, insider trading, and ownership report for Frank J. Hsu. You might contact Frank J. Hsu via mailing address: C/o Oncternal Therapeutics, Inc., 3525 Del Mar Heights Road #821, San Diego Ca 92130.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.